ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "1ac7b49d-e827-45e6-8451-74f381d7dced"}, "_deposit": {"id": "2016905", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "2016905"}, "status": "published"}, "_oai": {"id": "oai:u-ryukyu.repo.nii.ac.jp:02016905", "sets": ["1642838231558", "1642838412624"]}, "author_link": [], "item_1617186331708": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "A case of rectal cancer in which the administration of mFOLFOX6 plus cetuximab might have caused duodenal perforation", "subitem_1551255648112": "en"}]}, "item_1617186419668": {"attribute_name": "Creator", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Teruya, Tsuyoshi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Asato, Masaya", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Takushi, Yasukatsu", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nakachi, Atsushi", "creatorNameLang": "en"}]}]}, "item_1617186476635": {"attribute_name": "Access Rights", "attribute_value_mlt": [{"subitem_1522299639480": "open access", "subitem_1600958577026": "http://purl.org/coar/access_right/c_abf2"}]}, "item_1617186499011": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_1522650717957": "ja", "subitem_1522651041219": "琉球医学会"}]}, "item_1617186609386": {"attribute_name": "Subject", "attribute_value_mlt": [{"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "Unresectable rectal cancer"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "Duodenal perforation"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "mFOLFOX6 plus Cetuximab"}]}, "item_1617186626617": {"attribute_name": "Description", "attribute_value_mlt": [{"subitem_description": "Although cetuximab-containing chemotherapies are effective treatments for unresectable advanced colorectal cancer, characteristic side effects have been reported. Here, we report a case of rectal cancer in which duodenal perforation is likely to have occurred during the administration of mFOLFOX6 plus cetuximab as first-line chemotherapy. A 55-year-old woman complained of abdominal pain for several months. She was diagnosed with advanced rectal cancer and unresectable multiple liver and lung metastases. We initiated first-line chemotherapy with mFOLFOX6 plus cetuximab, which was administered with the expectation of early tumor shrinkage and consequent reductions in her abdominal pain. After 2 courses of chemotherapy, her abdominal symptom improved. However, after 4 courses of chemotherapy, she suddenly reported severe abdominal pain and was conveyed to our department. Abdominal computed tomography revealed intraabdominal free air, which we suspected was caused by gastrointestinal perforation. Urgent laparotomy was performed. We identified the perforation at the anterior wall of the duodenal bulb, closed the perforated site, and covered it with the omentum. In general, it has been reported that chemotherapy with cetuximab regimen is associated with some adverse events such as hematotoxicity, acne-like rash and hypersensitivity reaction. This time, we experienced a rare case of duodenal perforation that might have been associated with mFOLFOX6 plus cetuximab. We suggest that bowel perforation should be considered if a patient experiences sudden abdominal pain when receiving chemotherapy.", "subitem_description_type": "Other"}, {"subitem_description": "論文", "subitem_description_type": "Other"}]}, "item_1617186643794": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_1522300295150": "ja", "subitem_1522300316516": "琉球医学会"}, {"subitem_1522300295150": "en", "subitem_1522300316516": "Ryukyu Medical Association"}]}, "item_1617186702042": {"attribute_name": "Language", "attribute_value_mlt": [{"subitem_1551255818386": "eng"}]}, "item_1617186920753": {"attribute_name": "Source Identifier", "attribute_value_mlt": [{"subitem_1522646500366": "ISSN", "subitem_1522646572813": "1346-888X"}, {"subitem_1522646500366": "NCID", "subitem_1522646572813": "AN10369445"}]}, "item_1617186941041": {"attribute_name": "Source Title", "attribute_value_mlt": [{"subitem_1522650068558": "ja", "subitem_1522650091861": "琉球医学会誌 = Ryukyu Medical Journal"}]}, "item_1617187056579": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueNumber": "1-4", "bibliographicPageEnd": "104", "bibliographicPageStart": "97", "bibliographicVolumeNumber": "37"}]}, "item_1617258105262": {"attribute_name": "Resource Type", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_1617265215918": {"attribute_name": "Version Type", "attribute_value_mlt": [{"subitem_1522305645492": "VoR", "subitem_1600292170262": "http://purl.org/coar/version/c_970fb48d4fbd8a85"}]}, "item_1617605131499": {"attribute_name": "File", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "download_preview_message": "", "file_order": 0, "filename": "Vol37(1-4)p97.pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "", "size": 0, "url": {"objectType": "fulltext", "url": "https://u-ryukyu.repo.nii.ac.jp/record/2016905/files/Vol37(1-4)p97.pdf"}, "version_id": "46750d77-c122-4e4a-b5f1-be193ab40b6c"}]}, "item_title": "A case of rectal cancer in which the administration of mFOLFOX6 plus cetuximab might have caused duodenal perforation", "item_type_id": "15", "owner": "1", "path": ["1642838231558", "1642838412624"], "permalink_uri": "http://hdl.handle.net/20.500.12000/0002016905", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2019-11-29"}, "publish_date": "2019-11-29", "publish_status": "0", "recid": "2016905", "relation": {}, "relation_version_is_last": true, "title": ["A case of rectal cancer in which the administration of mFOLFOX6 plus cetuximab might have caused duodenal perforation"], "weko_shared_id": -1}
  1. 学術雑誌論文
  2. 琉球医学会
  3. 琉球医学会誌
  4. 37巻1-4号
  1. 部局別インデックス
  2. その他

A case of rectal cancer in which the administration of mFOLFOX6 plus cetuximab might have caused duodenal perforation

http://hdl.handle.net/20.500.12000/0002016905
http://hdl.handle.net/20.500.12000/0002016905
1d42e308-7be8-4622-8e88-ec679a918a86
名前 / ファイル ライセンス アクション
Vol37(1-4)p97.pdf Vol37(1-4)p97.pdf
Item type デフォルトアイテムタイプ(フル)(1)
公開日 2019-11-29
タイトル
タイトル A case of rectal cancer in which the administration of mFOLFOX6 plus cetuximab might have caused duodenal perforation
言語 en
作成者 Teruya, Tsuyoshi

× Teruya, Tsuyoshi

en Teruya, Tsuyoshi

Search repository
Asato, Masaya

× Asato, Masaya

en Asato, Masaya

Search repository
Takushi, Yasukatsu

× Takushi, Yasukatsu

en Takushi, Yasukatsu

Search repository
Nakachi, Atsushi

× Nakachi, Atsushi

en Nakachi, Atsushi

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
言語 ja
権利情報 琉球医学会
主題
言語 en
主題Scheme Other
主題 Unresectable rectal cancer
主題
言語 en
主題Scheme Other
主題 Duodenal perforation
主題
言語 en
主題Scheme Other
主題 mFOLFOX6 plus Cetuximab
内容記述
内容記述タイプ Other
内容記述 Although cetuximab-containing chemotherapies are effective treatments for unresectable advanced colorectal cancer, characteristic side effects have been reported. Here, we report a case of rectal cancer in which duodenal perforation is likely to have occurred during the administration of mFOLFOX6 plus cetuximab as first-line chemotherapy. A 55-year-old woman complained of abdominal pain for several months. She was diagnosed with advanced rectal cancer and unresectable multiple liver and lung metastases. We initiated first-line chemotherapy with mFOLFOX6 plus cetuximab, which was administered with the expectation of early tumor shrinkage and consequent reductions in her abdominal pain. After 2 courses of chemotherapy, her abdominal symptom improved. However, after 4 courses of chemotherapy, she suddenly reported severe abdominal pain and was conveyed to our department. Abdominal computed tomography revealed intraabdominal free air, which we suspected was caused by gastrointestinal perforation. Urgent laparotomy was performed. We identified the perforation at the anterior wall of the duodenal bulb, closed the perforated site, and covered it with the omentum. In general, it has been reported that chemotherapy with cetuximab regimen is associated with some adverse events such as hematotoxicity, acne-like rash and hypersensitivity reaction. This time, we experienced a rare case of duodenal perforation that might have been associated with mFOLFOX6 plus cetuximab. We suggest that bowel perforation should be considered if a patient experiences sudden abdominal pain when receiving chemotherapy.
内容記述
内容記述タイプ Other
内容記述 論文
出版者
言語 ja
出版者 琉球医学会
出版者
言語 en
出版者 Ryukyu Medical Association
言語
言語 eng
資源タイプ
資源タイプ journal article
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 1346-888X
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AN10369445
収録物名
言語 ja
収録物名 琉球医学会誌 = Ryukyu Medical Journal
書誌情報
巻 37, 号 1-4, p. 97-104
戻る
0
views
See details
Views

Versions

Ver.1 2022-02-22 07:19:21.926845
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3